[Guillain-Barr+e syndrome after autologous bone marrow transplantation].
Sánchez
C
C
Rodríguez Vicente
G
G
Caballero
M D
MD
Hernández
J M
JM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D016131:Lymphocyte Subsets; D008875:Middle Aged; D011129:Polyradiculoneuropathy / Q000097:blood / Q000209:etiology*; D014182:Transplantation, Autologous / Q000009:adverse effects*
D003561:Cytarabine; D003630:Daunorubicin
Sindrome de Guillain-Barré tras trasplante autólogo de medula ósea.